SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Juan J. Díez, Enrique Grande, Pedro Iglesias, Ablación posquirúrgica con radioyodo en pacientes con carcinoma diferenciado de tiroides de bajo riesgo, Medicina Clínica, 2014,

    CrossRef

  2. 2
    C.- H. Hsu, C.- L. Huang, Y.- H. Hsu, U. Iqbal, P.- A. Nguyen, W.- S. Jian, Co-occurrence of second primary malignancy in patients with thyroid cancer, QJM, 2014,

    CrossRef

  3. 3
    Melanie Goldfarb, Stephen F. Sener, Comparison of Radioiodine Utilization in Adolescent and Young Adult (AYA) and Older Thyroid Cancers Patients, Endocrine Practice, 2014, 1, -1, 1

    CrossRef

  4. 4
    Sofia Tsirona, Varvara Vlassopoulou, Marinella Tzanela, Phoebe Rondogianni, George Ioannidis, Charalambos Vassilopoulos, Efthimia Botoula, Panagiotis Trivizas, Ioannis Datseris, Stylianos Tsagarakis, Impact of early vs late postoperative radioiodine remnant ablation on final outcome in patients with low-risk well-differentiated thyroid cancer, Clinical Endocrinology, 2014, 80, 3
  5. 5
    Juan P Brito, Louise Davies, Claudia Zeballos-Palacios, John C Morris, Victor M Montori, Papillary lesions of indolent course: reducing the overdiagnosis of indolent papillary thyroid cancer and unnecessary treatment, Future Oncology, 2014, 10, 1, 1

    CrossRef

  6. 6
    Ye-Won Jeon, Young-Ee Ahn, Won-Sang Chung, Hyun-Joo Choi, Young Jin Suh, Radioactive iodine treatment for node negative papillary thyroid cancer with capsular invasion only: Results of a large retrospective study, Asia-Pacific Journal of Clinical Oncology, 2014, 10,
  7. 7
    Jian Tu, Siwen Wang, Zijun Huo, Ying Lin, Xiaoxi Li, Shenming Wang, Recombinant human thyrotropin-aided versus thyroid hormone withdrawal-aided radioiodine treatment for differentiated thyroid cancer after total thyroidectomy: A meta-analysis, Radiotherapy and Oncology, 2014, 110, 1, 25

    CrossRef

  8. 8
    Hiroshi Takami, Yasuhiro Ito, Takahiro Okamoto, Naoyoshi Onoda, Hitoshi Noguchi, Akira Yoshida, Revisiting the Guidelines Issued by the Japanese Society of Thyroid Surgeons and Japan Association of Endocrine Surgeons: A Gradual Move Towards Consensus Between Japanese and Western Practice in the Management of Thyroid Carcinoma, World Journal of Surgery, 2014,

    CrossRef

  9. 9
    Jose P. Zevallos, Li Xu, Yin Yiu, The Impact of Socioeconomic Status on the Use of Adjuvant Radioactive Iodine for Papillary Thyroid Cancer, Thyroid, 2014, 24, 4, 758

    CrossRef

  10. You have free access to this content10
    Jade A. U. Tamatea, Kelson Tu'akoi, John V. Conaglen, Marianne S. Elston, Goswin Y. Meyer-Rochow, Thyroid cancer in Graves’ disease: is surgery the best treatment for Graves’ disease?, ANZ Journal of Surgery, 2014, 84, 4
  11. 11
    Kenichi Matsuzu, Kiminori Sugino, Katsuhiko Masudo, Mitsuji Nagahama, Wataru Kitagawa, Hiroshi Shibuya, Keiko Ohkuwa, Takashi Uruno, Akifumi Suzuki, Syunsuke Magoshi, Junko Akaishi, Chie Masaki, Michikazu Kawano, Nobuyasu Suganuma, Yasushi Rino, Munetaka Masuda, Kaori Kameyama, Hiroshi Takami, Koichi Ito, Thyroid Lobectomy for Papillary Thyroid Cancer: Long-term Follow-up Study of 1,088 Cases, World Journal of Surgery, 2014, 38, 1, 68

    CrossRef

  12. 12
    Luís Gales, Jeffrey K. Aronson, A worldwide yearly survey of new data in adverse drug reactions and interactions, 2014,

    CrossRef

  13. 13
    Raymon H. Grogan, Sharone P. Kaplan, Hongyuan Cao, Roy E. Weiss, Leslie J. DeGroot, Cassie A. Simon, Omran M.A. Embia, Peter Angelos, Edwin L. Kaplan, Rebecca B. Schechter, A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up, Surgery, 2013, 154, 6, 1436

    CrossRef

  14. 14
    Maseeh Uz Zaman, Nosheen Fatima, Ajit Kumar Padhy, Unaiza Zaman, Controversies about Radioactive Iodine-131 Remnant Ablation in Low Risk Thyroid Cancers: Are We Near A Consensus?, Asian Pacific Journal of Cancer Prevention, 2013, 14, 11, 6209

    CrossRef

  15. 15
    Donald SA McLeod, Anna M Sawka, David S Cooper, Controversies in primary treatment of low-risk papillary thyroid cancer, The Lancet, 2013, 381, 9871, 1046

    CrossRef

  16. 16
    C. Durante, G. Costante, S. Filetti, Differentiated thyroid carcinoma: defining new paradigms for postoperative management, Endocrine Related Cancer, 2013, 20, 4, R141

    CrossRef

  17. 17
    Maria Papaleontiou, Mousumi Banerjee, Di Yang, James C. Sisson, Ronald J. Koenig, Megan R. Haymart, Factors That Influence Radioactive Iodine Use for Thyroid Cancer, Thyroid, 2013, 23, 2, 219

    CrossRef

  18. 18
    Antonis Valachis, Andreas Nearchou, High versus low radioiodine activity in patients with differentiated thyroid cancer: A meta-analysis, Acta Oncologica, 2013, 52, 6, 1055

    CrossRef

  19. 19
    Massimo Eugenio Dottorini, Massimo Salvatori, Is radioiodine treatment for thyroid cancer a risk factor for second primary malignancies?, Clinical and Translational Imaging, 2013, 1, 3, 205

    CrossRef

  20. 20
    Ashok R. Shaha, Low-risk Thyroid Cancer, Surgical Training, and Radioactive Iodine, Annals of Surgical Oncology, 2013, 20, 3, 703

    CrossRef

  21. 21
    Jin Chul Paeng, June-Key Chung, Methods and Clinical Efficacy of Dosimetry-Based Treatment in Radioiodine Therapy of Thyroid Cancer, Journal of Korean Thyroid Association, 2013, 6, 1, 43

    CrossRef

  22. 22
    Brooke E. Howitt, Yonghui Jia, Lynette M. Sholl, Justine A. Barletta, Molecular Alterations in Partially-Encapsulated or Well-Circumscribed Follicular Variant of Papillary Thyroid Carcinoma, Thyroid, 2013, 23, 10, 1256

    CrossRef

  23. You have free access to this content23
    David F. Schneider, Herbert Chen, New developments in the diagnosis and treatment of thyroid cancer, CA: A Cancer Journal for Clinicians, 2013, 63, 6
  24. 24
    David E. Gyorki, Brian Untch, R. Michael Tuttle, Ashok R. Shaha, Prophylactic Central Neck Dissection in Differentiated Thyroid Cancer: An Assessment of the Evidence, Annals of Surgical Oncology, 2013, 20, 7, 2285

    CrossRef

  25. 25
    Monireh Hedayati, Nayereh Shafaghati, Seyed Jalal Hosseinimehr, Resveratrol mitigates genotoxicity induced by iodine-131 in primary human lymphocytes, Radiation and Environmental Biophysics, 2013, 52, 2, 287

    CrossRef

  26. 26
    Marina Vivero, Stefan Kraft, Justine A. Barletta, Risk Stratification of Follicular Variant of Papillary Thyroid Carcinoma, Thyroid, 2013, 23, 3, 273

    CrossRef

  27. 27
    Kathryn M. Schuessler, Mousumi Banerjee, Di Yang, Andrew K. Stewart, Gerard M. Doherty, Megan R. Haymart, Surgeon Training and Use of Radioactive Iodine in Stage I Thyroid Cancer Patients, Annals of Surgical Oncology, 2013, 20, 3, 733

    CrossRef

  28. 28
    Briseis Aschebrook-Kilfoy, Edwin L. Kaplan, Brian C.-H. Chiu, Peter Angelos, Raymon H. Grogan, The Acceleration in Papillary Thyroid Cancer Incidence Rates is Similar Among Racial and Ethnic Groups in the United States, Annals of Surgical Oncology, 2013, 20, 8, 2746

    CrossRef

  29. 29
    Iain J. Nixon, Ian Ganly, Snehal G. Patel, Frank L. Palmer, Monica M. Di Lorenzo, Ravinder K. Grewal, Steven M. Larson, R. Michael Tuttle, Ashok Shaha, Jatin P. Shah, The Results of Selective Use of Radioactive Iodine on Survival and on Recurrence in the Management of Papillary Thyroid Cancer, Based on Memorial Sloan-Kettering Cancer Center Risk Group Stratification, Thyroid, 2013, 23, 6, 683

    CrossRef

  30. 30
    Megan R. Haymart, Mousumi Banerjee, Di Yang, Andrew K. Stewart, Ronald J. Koenig, Jennifer J. Griggs, The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer, Cancer, 2013, 119, 2
  31. 31
    Nikolaos A. Trikalinos, Qing Chen, Yi Ning, Edward A. Sausville, Maria R. Baer, Unbalanced 11;18 translocation in an acute erythroid leukemia after radioactive iodine therapy, Cancer Genetics, 2013, 206, 6, 252

    CrossRef

  32. 32
    Supriya S Patel, Melanie Goldfarb, Well-differentiated thyroid carcinoma: The role of post-operative radioactive iodine administration, Journal of Surgical Oncology, 2013, 107, 6
  33. 33
    Ujjal Mallick, Clive Harmer, Beng Yap, Jonathan Wadsley, Susan Clarke, Laura Moss, Alice Nicol, Penelope M. Clark, Kate Farnell, Ralph McCready, James Smellie, Jayne A. Franklyn, Rhys John, Christopher M. Nutting, Kate Newbold, Catherine Lemon, Georgina Gerrard, Abdel Abdel-Hamid, John Hardman, Elena Macias, Tom Roques, Stephen Whitaker, Rengarajan Vijayan, Pablo Alvarez, Sandy Beare, Sharon Forsyth, Latha Kadalayil, Allan Hackshaw, Ablation with Low-Dose Radioiodine and Thyrotropin Alfa in Thyroid Cancer, New England Journal of Medicine, 2012, 366, 18, 1674

    CrossRef

  34. 34
    Robert Bublak, Häufig Zweitmalignome nach Radiojodtherapie, HNO Nachrichten, 2012, 42, 1, 16

    CrossRef

  35. 35
    U. Mallick, C. Harmer, A. Hackshaw, L. Moss, Iodine or Not (IoN) for Low-risk Differentiated Thyroid Cancer: The Next UK National Cancer Research Network Randomised Trial following HiLo, Clinical Oncology, 2012, 24, 3, 159

    CrossRef

  36. 36
    Antoinette M. Stroup, C. Janna Harrell, Kimberly A. Herget, Long-Term Survival in Young Women: Hazards and Competing Risks after Thyroid Cancer, Journal of Cancer Epidemiology, 2012, 2012, 1

    CrossRef

  37. 37
    Diana L. Diesen, Michael A. Skinner, Pediatric thyroid cancer, Seminars in Pediatric Surgery, 2012, 21, 1, 44

    CrossRef

  38. 38
    Erik K. Alexander, P. Reed Larsen, Radioiodine for Thyroid Cancer — Is Less More?, New England Journal of Medicine, 2012, 366, 18, 1732

    CrossRef

  39. 39
    Marilee Carballo, Roderick M. Quiros, To Treat or Not to Treat: The Role of Adjuvant Radioiodine Therapy in Thyroid Cancer Patients, Journal of Oncology, 2012, 2012, 1

    CrossRef

  40. 40
    Tihana Ibrahimpasic, Iain J. Nixon, Frank L. Palmer, Monica M. Whitcher, Robert M. Tuttle, Ashok Shaha, Snehal G. Patel, Jatin P. Shah, Ian Ganly, Undetectable thyroglobulin after total thyroidectomy in patients with low- and intermediate-risk papillary thyroid cancer— is there a need for radioactive iodine therapy?, Surgery, 2012, 152, 6, 1096

    CrossRef